Correlation Between Sartorius Stedim and Resmed

Can any of the company-specific risk be diversified away by investing in both Sartorius Stedim and Resmed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sartorius Stedim and Resmed into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sartorius Stedim Biotech and Resmed Inc DRC, you can compare the effects of market volatilities on Sartorius Stedim and Resmed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sartorius Stedim with a short position of Resmed. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sartorius Stedim and Resmed.

Diversification Opportunities for Sartorius Stedim and Resmed

-0.21

Correlation Coefficient

Sartorius Stedim  Resmed

Very good diversification

The 3 months correlation between Sartorius and Resmed is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Sartorius Stedim Biotech and Resmed Inc DRC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Resmed Inc DRC and Sartorius Stedim is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sartorius Stedim Biotech are associated (or correlated) with Resmed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Resmed Inc DRC has no effect on the direction of Sartorius Stedim i.e., Sartorius Stedim and Resmed go up and down completely randomly.

Pair Corralation between Sartorius Stedim and Resmed

Assuming the 90 days trading horizon Sartorius Stedim Biotech is expected to under-perform the Resmed. In addition to that, Sartorius Stedim is 1.35 times more volatile than Resmed Inc DRC. It trades about -0.02 of its total potential returns per unit of risk. Resmed Inc DRC is currently generating about 0.02 per unit of volatility. If you would invest  2,076  in Resmed Inc DRC on October 12, 2024 and sell it today you would earn a total of  164.00  from holding Resmed Inc DRC or generate 7.9% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Sartorius Stedim Biotech  vs.  Resmed Inc DRC

Sartorius Stedim Biotech

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Sartorius Stedim Biotech are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Sartorius Stedim may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Resmed Inc DRC

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Resmed Inc DRC are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable technical and fundamental indicators, Resmed is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Sartorius Stedim and Resmed

The main advantage of trading using opposite Sartorius Stedim and Resmed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sartorius Stedim position performs unexpectedly, Resmed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Resmed will offset losses from the drop in Resmed's long position.

The idea behind Sartorius Stedim Biotech and Resmed Inc DRC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..